Those living with frequent migraine attacks are invited to join.
Momentum Clinical Research is conducting a research study for a potential new treatment for the prevention of migraine. The trials are taking place at their clinic sites in Auckland, Kapiti, Wellington and Christchurch, and participants will be reimbursed up to $2,380 (less tax).
You may qualify for this study if you:
- are aged 18 to 64 years
- have tried between 1–4 preventive migraine medications, at least one that did not work
- have not taken preventive migraine treatments in the past three months
- are not currently pregnant or breastfeeding
- are willing and able to follow all study requirements, including use of contraception where applicable.
Other criteria will apply.
More information about the trial
Researchers are evaluating an investigational treatment in the form of an oral tablet, designed to help prevent migraine. The goal is to determine whether this treatment can successfully reduce monthly migraine days by disrupting specific inflammatory pathways involved in migraine pain.
If you’re eligible and choose to participate, the study will involve around seven clinic visits over a duration of approximately 21 weeks. All participants will receive study-related health checks and advice from the study medical team throughout the trial.
For more information and to register your interest, please visit one of the research sites below. The study team will be in touch to answer any questions and run through further eligibility criteria and screening procedures.
